Elevance Health Aktie
279,90
EUR
-1,60
EUR
-0,57
%
325,87
USD
-2,49
USD
-0,76
%
Werbung
Elevance Health Aktie Analyse
| 01.11.18 | Elevance Health overweight | Barclays Capital | |
| 13.07.18 | Elevance Health Outperform | BMO Capital Markets | |
| 08.03.18 | Elevance Health overweight | Barclays Capital | |
| 06.12.17 | Elevance Health Buy | B. Riley FBR, Inc. | |
| 20.10.17 | Elevance Health Market Perform | BMO Capital Markets | |
| 27.04.17 | Elevance Health Outperform | RBC Capital Markets | |
| 02.02.17 | Elevance Health Outperform | RBC Capital Markets | |
| 04.01.17 | Elevance Health Hold | Stifel, Nicolaus & Co., Inc. | |
|
Werbung
|
|||
| 30.10.15 | Elevance Health Market Perform | BMO Capital Markets | |
| 29.10.15 | Elevance Health Outperform | Oppenheimer & Co. Inc. | |
| 29.10.15 | Elevance Health Outperform | RBC Capital Markets | |
| 30.07.15 | Elevance Health Outperform | Oppenheimer & Co. Inc. | |
| 30.07.15 | Elevance Health Outperform | RBC Capital Markets | |
| 24.06.15 | Elevance Health Outperform | RBC Capital Markets | |
| 30.04.15 | Elevance Health Outperform | Oppenheimer & Co. Inc. | |
| 16.04.15 | Elevance Health Outperform | Oppenheimer & Co. Inc. | |
| 29.01.15 | Elevance Health Buy | Deutsche Bank AG | |
| 06.01.15 | Elevance Health Buy | Deutsche Bank AG | |
Werbung
Werbung